Infinity Pharmaceuticals, Inc.
US ˙ OTCPK ˙ US45665G3039

Introduction

This page provides a comprehensive analysis of the known insider trading history of Steven H Holtzman. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Steven H Holtzman has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
Director 108,946
US:BIIB / Biogen Inc. EVP Corporate Development 3,462
US:INFI / Infinity Pharmaceuticals Inc. Director 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Steven H Holtzman. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases INFIQ / Infinity Pharmaceuticals, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in INFIQ / Infinity Pharmaceuticals, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

INFIQ / Infinity Pharmaceuticals, Inc. Insider Trades
Insider Sales INFIQ / Infinity Pharmaceuticals, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in INFIQ / Infinity Pharmaceuticals, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2012-05-31 INFI Holtzman Steven H 57,573 13.0100 57,573 13.0100 749,025 5 11.84 -67,360 -8.99
2012-05-30 INFI Holtzman Steven H 10,958 13.0000 10,958 13.0000 142,454
2012-05-29 INFI Holtzman Steven H 189,303 13.0000 189,303 13.0000 2,460,939

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

INFIQ / Infinity Pharmaceuticals, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Steven H Holtzman as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2024-10-15 2024-10-15 4 CAMP Camp4 Therapeutics Corp
Common Stock
C - Conversion 8,917 108,946 8.91
2024-10-10 3 CAMP Camp4 Therapeutics Corp
Common Stock
100,029
2016-02-25 2016-02-23 4 BIIB BIOGEN INC.
Restricted Stock Unit
J - Other -1,149 3,462 -24.92
2016-02-25 2016-02-23 4 BIIB BIOGEN INC.
Restricted Stock Unit
M - Exercise -579 4,611 -11.16
2016-02-25 2016-02-23 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -273 8,326 -3.17 258.99 -70,704 2,156,351
2016-02-25 2016-02-23 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 579 8,599 7.22
2016-02-17 2016-02-12 4 BIIB BIOGEN INC.
Restricted Stock Unit
J - Other -1,394 2,448 -36.28
2016-02-17 2016-02-12 4 BIIB BIOGEN INC.
Restricted Stock Unit
M - Exercise -2,142 2,147 -49.94
2016-02-17 2016-02-12 4 BIIB BIOGEN INC.
Restricted Stock Unit
M - Exercise -1,052 3,842 -21.50
2016-02-17 2016-02-12 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -819 8,020 -9.27 247.22 -202,473 1,982,704
2016-02-17 2016-02-12 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 2,142 8,839 31.98
2016-02-17 2016-02-12 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -495 6,697 -6.88 247.22 -122,374 1,655,632
2016-02-17 2016-02-12 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 1,052 7,192 17.13
2016-02-09 2016-02-08 4 BIIB BIOGEN INC.
Restricted Stock Unit
M - Exercise -2,709 0 -100.00
2016-02-09 2016-02-08 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -890 6,140 -12.66 250.77 -223,185 1,539,728
2016-02-09 2016-02-08 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 2,709 7,030 62.69
2015-02-25 2015-02-23 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
A - Award 5,190 5,190
2015-02-18 2015-02-17 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -2,128 4,321 -33.00 389.11 -828,026 1,681,344
2015-02-17 2015-02-12 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
J - Other -954 4,894 -16.31
2015-02-17 2015-02-12 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -1,492 5,848 -20.33
2015-02-17 2015-02-12 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -2,142 4,289 -33.31
2015-02-17 2015-02-12 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -703 6,449 -9.83 392.11 -275,653 2,528,717
2015-02-17 2015-02-12 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 1,492 7,152 26.36
2015-02-17 2015-02-12 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -1,009 5,660 -15.13 392.11 -395,639 2,219,343
2015-02-17 2015-02-12 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 2,142 6,669 47.32
2015-02-10 2015-02-08 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -2,705 2,709 -49.96
2015-02-10 2015-02-08 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -1,275 4,527 -21.98 402.00 -512,550 1,819,854
2015-02-10 2015-02-08 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 2,705 5,802 87.34
2015-02-02 2015-02-01 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -5,157 0 -100.00
2015-02-02 2015-02-01 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -2,060 3,097 -39.95 389.16 -801,670 1,205,229
2015-02-02 2015-02-01 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 5,157 5,157
2014-12-03 2014-12-02 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1,749 0 -100.00 335.65 -587,052
2014-11-12 2014-11-11 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1,750 1,749 -50.01 330.00 -577,500 577,170
2014-10-02 2014-10-01 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1,750 3,499 -33.34 330.97 -579,198 1,158,064
2014-09-22 2014-09-18 4 BIIB BIOGEN IDEC INC.
Common Stock
G - Gift -500 5,249 -8.70
2014-05-20 2014-05-19 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1,221 5,749 -17.52 289.15 -353,052 1,662,323
2014-04-21 2014-04-17 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1,221 6,970 -14.91 291.00 -355,311 2,028,270
2014-03-18 2014-03-17 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1,221 8,191 -12.97 334.83 -408,827 2,742,593
2014-02-19 2014-02-18 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1,222 9,412 -11.49 327.90 -400,694 3,086,195
2014-02-14 2014-02-12 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
A - Award 7,340 7,340
2014-02-14 2014-02-12 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -2,142 6,431 -24.99
2014-02-14 2014-02-12 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -1,010 10,634 -8.67 323.04 -326,270 3,435,207
2014-02-14 2014-02-12 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 2,142 11,644 22.54
2014-02-11 2014-02-08 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -2,705 5,414 -33.32
2014-02-11 2014-02-08 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -1,276 9,502 -11.84 315.54 -402,629 2,998,261
2014-02-11 2014-02-08 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 2,705 10,778 33.51
2014-02-03 2014-02-01 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -5,159 5,157 -50.01
2014-02-03 2014-02-01 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -1,971 8,073 -19.62 312.64 -616,213 2,523,943
2014-02-03 2014-02-01 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 5,159 10,044 105.61
2013-09-18 2013-09-17 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -3,501 4,885 -41.75 238.98 -836,669 1,167,417
2013-02-14 2013-02-12 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
A - Award 8,573 8,573
2013-02-12 2013-02-08 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
J - Other -361 8,119 -4.26
2013-02-12 2013-02-08 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -2,344 8,480 -21.66
2013-02-12 2013-02-08 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -940 8,386 -10.08 164.44 -154,574 1,378,994
2013-02-12 2013-02-08 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 2,344 9,326 33.57
2013-02-05 2013-02-01 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -5,159 10,316 -33.34
2013-02-05 2013-02-01 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -1,678 6,982 -19.38 157.30 -263,949 1,098,269
2013-02-05 2013-02-01 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 5,159 8,660 147.36
2012-06-04 2012-05-31 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
S - Sale -57,573 0 -100.00 13.01 -749,025
2012-05-31 2012-05-30 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
S - Sale -10,958 57,573 -15.99 13.00 -142,454 748,449
2012-05-31 2012-05-29 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
S - Sale -189,303 68,531 -73.42 13.00 -2,460,939 890,903
2012-05-31 2012-05-18 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
G - Gift -15,000 257,834 -5.50
2012-05-18 2012-05-16 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 12,000 12,000
2012-05-18 2012-05-16 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 6,000 6,000
2012-02-10 2012-02-08 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
A - Award 10,824 10,824
2012-02-03 2012-02-01 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -5,159 15,475 -25.00
2012-02-03 2012-02-01 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -1,658 3,501 -32.14 121.26 -201,049 424,531
2012-02-03 2012-02-01 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 5,159 5,159
2011-02-03 2011-02-01 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
A - Award 20,634 20,634
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)